Page 65 - Read Online

Page6 of 6 Carvalho et al. Hepatoma Res 2020;6:6 I http://dx.doi.org/10.20517/2394-5079.2019.027

13. Pedro JMB, Kroemer G, Filigheddu N, Galluzzi L, Porporato PE. Mitochondrial metabolism and cancer. Cell Res 2017;28:265-80.
14. Dhanasekaran R, Bandoh S, Roberts LR. Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances.
F1000Res 2016;5:879.
15. Okano J, Nagahara T, Matsumoto K, Murawaki Y. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/
EGFR signalling pathway. Basic Clin Pharmacol Toxicol 2008;102:543-51.
16. Cavin C, Holzhaeuser D, Scharf G, Huber WW, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic
activity. Food Chem Toxicol 2002;40:1155-63.
17. Huber WW, Scharf G, Rossmanith W, Prustomersky S, Grasl-Kraupp B, et al. The coffee components kahweol and cafestol induce
gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat.
Arch Toxicol 2002;75:685-94.
18. Tanaka K, Hara M, Sakamoto T, Higaki Y, Mizuta T, et al. Inverse association between coffee drinking and the risk of hepatocellular
carcinoma: a case-control study in Japan. Cancer Sci 2007;98:214-8.
19. Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, et al. Joint effects of coffee consumption and serum gamma-
glutamyltransferase on the risk of liver cancer. Hepatology 2008;48:129-36.
20. Cano-Marquina A, Tarín JJ, Cano A. The impact of coffee on health. Maturitas 2013;75:7-21.
21. Inoue M, Yoshimi I, Sobue T, Tsugane S; JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular
carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005;97:293-300.
22. Johnson S, Wang R. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health
Study. Cancer Causes Control 2012;22:503-10.
23. Bamia C, Lagiou P, Jenab M, Trichopoulou A, Fedirko V, et al. Coffee, tea and decaffeinated coffee in relation to hepatocellular
carcinoma in a European population: multicentre, prospective cohort study. Int J Cancer 2015;136:1899-908.
24. Aleksandrova K, Bamia C, Drogan D, Lagiou P, Trichopoulou A, et al. The association of coffee intake with liver cancer risk is
mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and
Nutrition. Am J Clin Nutr 2015;102:1498-508.
25. Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, et al. Coffee and risk of death from hepatocellular carcinoma in a large
cohort study in Japan. Br J Cancer 2005;93:607-10.
26. Kondili LA, Lala A, Gunson B, Hubscher S, Olliff S, et al. Primary hepatocellular cancer in the explanted liver: outcome of
transplantation and risk factors for HCC recurrence. Eur J Surg Oncol 2007;33:868-73.
27. Eini H, Frishman V, Yulzari R, Kachko L, Lewis EC, et al. Caffeine promotes anti-tumor immune response during tumor initiation:
involvement of the adenosine A2A receptor. Biochem Pharmacol 2015;98:110-8.